Scott Callie A, Yeshiwondim Asnakew K, Serda Belendia, Guinovart Caterina, Tesfay Berhane H, Agmas Adem, Zeleke Melkamu T, Guesses Girma S, Ayenew Asmamaw L, Workie Worku M, Steketee Richard W, Earle Duncan, Bezabih Belay, Getachew Asefaw
PATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
PATH Malaria Control and Elimination Partnership in Africa (MACEPA), Getu Commercial Center, Rear Side, 1st-4th Floors, PO Box 493, 1110, Addis Ababa, Ethiopia.
Malar J. 2016 Jun 2;15:305. doi: 10.1186/s12936-016-1333-3.
In areas with ongoing malaria transmission, strategies to clear parasites from populations can reduce infection and transmission. The objective of this paper was to describe a malaria mass testing and treatment (MTAT) intervention implemented in six kebeles (villages) in Amhara Region, Ethiopia, at the beginning of the 2014 transmission season.
Intervention kebeles were selected based on incidence of passively detected Plasmodium falciparum and mixed (P. falciparum and P. vivax) malaria cases during the 2013 malaria transmission season. All households in intervention kebeles were targeted; consenting residents received a rapid diagnostic test (RDT) and RDT-positive individuals received artemether-lumefantrine for P. falciparum/mixed infections or chloroquine for P. vivax. Data were collected on MTAT participation, sociodemographic characteristics, malaria risk factors, and RDT positivity.
Of 9162 households targeted, 7974 (87.0 %) participated in the MTAT. Among the 35,389 residents of these households, 30,712 (86.8 %) received an RDT. RDT-positivity was 1.4 % (0.3 % P. vivax, 0.7 % P. falciparum, 0.3 % mixed), ranging from 0.3 to 5.1 % by kebele; 39.4 % of RDT-positive individuals were febrile, 28.5 % resided in the same household with another RDT-positive individual, 23.0 % were not protected by vector control interventions [mosquito net or indoor residual spray (IRS)], and 7.1 % had travel history. For individuals under 10 years of age, the odds of being RDT-positive was significantly higher for those with fever, recent use of anti-malarial drugs or residing in the same household with another RDT-positive individual; 59.0 % of RDT-positive individuals had at least one of these risk factors. For individuals 10 years of age and older, the odds of being RDT positive was significantly higher for those with reported travel, fever, recent use of anti-malarial drugs, no use of vector control, and those residing in the same household as another RDT-positive individual; 71.2 % of RDT-positive individuals had at least one of these risk factors.
In the Ethiopia setting, an MTAT intervention is operationally feasible and can be conducted with high coverage. RDT-positivity is low and varies widely by kebele. While several risk factors are significantly associated with RDT-positivity, there are still many RDT-positive individuals who do not have any of these risk factors. Strategies that target populations for testing and treatment based on these risk factors alone are likely to leave many infections undetected.
在疟疾持续传播的地区,清除人群中疟原虫的策略可减少感染和传播。本文的目的是描述2014年传播季节开始时在埃塞俄比亚阿姆哈拉地区六个村落实施的疟疾大规模检测和治疗(MTAT)干预措施。
根据2013年疟疾传播季节被动检测到的恶性疟原虫和混合(恶性疟原虫和间日疟原虫)疟疾病例的发病率选择干预村落。干预村落的所有家庭均为目标对象;同意参与的居民接受快速诊断检测(RDT),RDT检测呈阳性的个体针对恶性疟原虫/混合感染接受蒿甲醚-本芴醇治疗,针对间日疟原虫接受氯喹治疗。收集了关于MTAT参与情况、社会人口学特征、疟疾危险因素和RDT阳性率的数据。
在9162个目标家庭中,7974个(87.0%)参与了MTAT。在这些家庭的35389名居民中,30712名(86.8%)接受了RDT检测。RDT阳性率为1.4%(间日疟原虫0.3%,恶性疟原虫0.7%,混合感染0.3%),各村落的阳性率在0.3%至5.1%之间;39.4%的RDT阳性个体发热,28.5%与另一名RDT阳性个体居住在同一家庭,23.0%未受到病媒控制干预措施(蚊帐或室内滞留喷洒)的保护,7.1%有旅行史。对于10岁以下个体,发热、近期使用抗疟药物或与另一名RDT阳性个体居住在同一家庭的个体RDT检测呈阳性的几率显著更高;59.0%的RDT阳性个体至少有这些危险因素中的一项。对于10岁及以上个体,报告有旅行、发热、近期使用抗疟药物、未使用病媒控制措施以及与另一名RDT阳性个体居住在同一家庭的个体RDT检测呈阳性的几率显著更高;71.2%的RDT阳性个体至少有这些危险因素中的一项。
在埃塞俄比亚的环境下,MTAT干预措施在操作上是可行的,并且可以实现高覆盖率。RDT阳性率较低,且各村落差异很大。虽然有几个危险因素与RDT阳性率显著相关,但仍有许多RDT阳性个体没有这些危险因素中的任何一项。仅基于这些危险因素对人群进行检测和治疗的策略可能会使许多感染未被发现。